News

MPS PHARMAA Limited, formerly Advik Laboratories Limited, submitted a certificate to the Bombay Stock Exchange and Ahmedabad Stock Exchange on October 7, 2026, confirming compliance with Regulation 74(5) of the SEBI (Depository and Participant) Regulations, 2018, for the quarter and half year ended September 30, 2026, as per confirmation provided by MAS Services Private Limited, the company`s Registrar and Share Transfer Agent.

MPS Pharmaa Limited, formerly Advik Laboratories Limited, said shareholders at its 32nd Annual General Meeting on September 29, 2026, approved the re-appointment of Mr. Ram Niwas Sharma as a Non-Executive Director, the appointment of Ms. Anchal Goyal as an Independent Director, and the re-appointment of M/s. Nemani Garg Agarwal & Co. as Statutory Auditors for a five-year term. The company also adopted its audited financial statements for the year ended March 31, 2026, and approved related party transactions.

MPS Pharmaa Limited, formerly Advik Laboratories Limited, announced that shareholders at its 32nd Annual General Meeting on September 29, 2026, approved the company’s financial statements for the year ended March 31, 2026, re-appointed Ram Niwas Sharma as a Non-Executive Director, re-appointed M/s. Nemani Garg Agarwal & Co. as statutory auditors for a five-year term, approved related party transactions, and appointed Anchal Goyal as an Independent Director for five years.

MPS Pharmaa Limited, formerly Advik Laboratories Limited, announced that shareholders at its 32nd Annual General Meeting on September 29, 2026, approved the company’s financial statements for the year ended March 31, 2026, re-appointed Ram Niwas Sharma as a Non-Executive Director, re-appointed M/s. Nemani Garg Agarwal & Co. as statutory auditors for a five-year term, approved related party transactions, and appointed Anchal Goyal as an Independent Director for five years.

MPS Pharmaa Limited, formerly Advik Laboratories Limited, will close its trading window for directors, promoters, key managerial personnel, other designated persons/employees and their immediate relatives from October 1, 2026, until 48 hours after the unaudited financial results for the quarter and half year ending September 30, 2026, are made public, according to a filing with the BSE Limited.